Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Published on 31 Jan 2025 on Zacks · via Yahoo Finance

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Read the rest of the article

Start tracking your investments with Statfolio

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Zacks · via Yahoo Finance 24 Feb 2025

On Wednesday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported fourth-quarter adjusted EPS of ...

Benzinga · via Yahoo Finance 21 Feb 2025

BMRN reports better-than-expected fourth-quarter results, driven by encouraging uptake for Voxzog...

Zacks · via Yahoo Finance 20 Feb 2025

King & Spalding partner Jamieson Greer reported earning more than $1.467 million from his work wi...

Law.com 19 Feb 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 17 Feb 2025

Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise...

Zacks · via Yahoo Finance 17 Feb 2025

However, the growth potential is expected to have been partially offset by lower Kuvan sales. BMR...

Zacks · via Yahoo Finance 17 Feb 2025

The FDA approves AXSM's Symbravo for the acute treatment of migraine with or without aura in adul...

Zacks · via Yahoo Finance 1 Feb 2025

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid...

Zacks · via Yahoo Finance 31 Jan 2025

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Zacks · via Yahoo Finance 31 Jan 2025